Literature DB >> 21054801

Arginase II deletion increases corpora cavernosa relaxation in diabetic mice.

Haroldo A Toque1, Rita C Tostes, Lin Yao, Zhimin Xu, R Clinton Webb, Ruth B Caldwell, R William Caldwell.   

Abstract

INTRODUCTION: Diabetes-induced erectile dysfunction involves elevated arginase (Arg) activity and expression. Because nitric oxide (NO) synthase and Arg share and compete for their substrate L-arginine, NO production is likely linked to regulation of Arg. Arg is highly expressed and implicated in erectile dysfunction. AIM: It was hypothesized that Arg-II isoform deletion enhances relaxation function of corpora cavernosal (CC) smooth muscle in a streptozotocin (STZ) diabetic model.
METHODS: Eight weeks after STZ-induced diabetes, vascular functional studies, Arg activity assay, and protein expression levels of Arg and constitutive NOS (using Western blots) were assessed in CC tissues from nondiabetic wild type (WT), diabetic (D) WT (WT + D), Arg-II knockout (KO), and Arg-II KO+D mice (N = 8-10 per group). MAIN OUTCOME MEASURES: Inhibition or lack of arginase results in facilitation of CC relaxation in diabetic CC.
RESULTS: Strips of CC from Arg-II KO mice exhibited an enhanced maximum endothelium-dependent relaxation (from 70 + 3% to 84 + 4%) and increased nitrergic relaxation (by 55%, 71%, 42%, 42%, and 24% for 1, 2, 4, 8 and 16 Hz, respectively) compared with WT mice. WT + D mice showed a significant reduction of endothelium-dependent maximum relaxation (44 + 8%), but this impairment of relaxation was significantly prevented in Arg-II KO+D mice (69 + 4%). Sympathetic-mediated and alpha-adrenergic agent-induced contractile responses also were increased in CC strips from D compared with non-D controls. Contractile responses were significantly lower in Arg-II KO control and D versus the WT groups. WT + D mice increased Arg activity (1.5-fold) and Arg-II protein expression and decreased total and phospho-eNOS at Ser-1177, and nNOS levels. These alterations were not seen in Arg-II KO mice. Additionally, the Arg inhibitor BEC (50 µM) enhanced nitrergic and endothelium-dependent relaxation in CC of WT + D mice.
CONCLUSION: These studies show for the first time that Arg-II deletion improves CC relaxation in type 1 diabetes.
© 2010 International Society for Sexual Medicine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21054801      PMCID: PMC3117078          DOI: 10.1111/j.1743-6109.2010.02098.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  49 in total

1.  Arginase pathway in human endothelial cells in pathophysiological conditions.

Authors:  Tiziana Bachetti; Laura Comini; Gloria Francolini; Daniela Bastianon; Barbara Valetti; Moris Cadei; PierGiovanni Grigolato; Hisanori Suzuki; Dario Finazzi; Alberto Albertini; Salvatore Curello; Roberto Ferrari
Journal:  J Mol Cell Cardiol       Date:  2004-08       Impact factor: 5.000

Review 2.  Urologic complications of diabetes.

Authors:  Jeanette S Brown; Hunter Wessells; Michael B Chancellor; Stuart S Howards; Walter E Stamm; Ann E Stapleton; William D Steers; Stephen K Van Den Eeden; Kevin T McVary
Journal:  Diabetes Care       Date:  2005-01       Impact factor: 19.112

3.  Arginase inhibition restores arteriolar endothelial function in Dahl rats with salt-induced hypertension.

Authors:  Fruzsina K Johnson; Robert A Johnson; Kelly J Peyton; William Durante
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-12-09       Impact factor: 3.619

4.  Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction.

Authors:  Biljana Musicki; Melissa F Kramer; Robyn E Becker; Arthur L Burnett
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-05       Impact factor: 11.205

5.  Arginase inhibition reduces endothelial dysfunction and blood pressure rising in spontaneously hypertensive rats.

Authors:  Céline Demougeot; Anne Prigent-Tessier; Christine Marie; Alain Berthelot
Journal:  J Hypertens       Date:  2005-05       Impact factor: 4.844

6.  Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction.

Authors:  Xiu-Fen Ming; Christine Barandier; Hema Viswambharan; Brenda R Kwak; François Mach; Lucia Mazzolai; Daniel Hayoz; Jean Ruffieux; Sandro Rusconi; Jean-Pierre Montani; Zhihong Yang
Journal:  Circulation       Date:  2004-11-29       Impact factor: 29.690

7.  Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS.

Authors:  A D Seftel; N D Vaziri; Z Ni; K Razmjouei; J Fogarty; N Hampel; J Polak; R Z Wang; K Ferguson; C Block; C Haas
Journal:  Urology       Date:  1997-12       Impact factor: 2.649

8.  Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells.

Authors:  Louis G Chicoine; Michael L Paffett; Tamara L Young; Leif D Nelin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-02-20       Impact factor: 5.464

9.  RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction.

Authors:  Trinity J Bivalacqua; Hunter C Champion; Mustafa F Usta; Selim Cellek; Kanchan Chitaley; R Clinton Webb; Ronald L Lewis; Thomas M Mills; Wayne J G Hellstrom; Philip J Kadowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

10.  Augmented contractile response of vascular smooth muscle in a diabetic mouse model.

Authors:  Elena B Okon; Tania Szado; Ismail Laher; Bruce McManus; Cornelis van Breemen
Journal:  J Vasc Res       Date:  2003-11-27       Impact factor: 1.934

View more
  23 in total

1.  Hyperglycemia-impaired aortic vasorelaxation mediated through arginase elevation: Role of stress kinase pathways.

Authors:  Surabhi Chandra; David J R Fulton; Ruth B Caldwell; R William Caldwell; Haroldo A Toque
Journal:  Eur J Pharmacol       Date:  2018-11-28       Impact factor: 4.432

Review 2.  Arginase: an old enzyme with new tricks.

Authors:  Ruth B Caldwell; Haroldo A Toque; S Priya Narayanan; R William Caldwell
Journal:  Trends Pharmacol Sci       Date:  2015-04-27       Impact factor: 14.819

3.  Deficient arginase II expression without alteration in arginase I expression attenuated experimental autoimmune encephalomyelitis in mice.

Authors:  Mariam Choudry; Xiaolei Tang; Tiffany Santorian; Samiksha Wasnik; Jidong Xiao; Weirong Xing; Kin-Hing William Lau; Subburaman Mohan; David J Baylink; Xuezhong Qin
Journal:  Immunology       Date:  2018-04-16       Impact factor: 7.397

4.  The role of arginase I in diabetes-induced retinal vascular dysfunction in mouse and rat models of diabetes.

Authors:  S C Elms; H A Toque; M Rojas; Z Xu; R W Caldwell; R B Caldwell
Journal:  Diabetologia       Date:  2012-12-12       Impact factor: 10.122

5.  p38 Mitogen-activated protein kinase (MAPK) increases arginase activity and contributes to endothelial dysfunction in corpora cavernosa from angiotensin-II-treated mice.

Authors:  Haroldo A Toque; Maritza J Romero; Rita C Tostes; Alia Shatanawi; Surabhi Chandra; Zidonia N Carneiro; Edward W Inscho; Robert Clinton Webb; Ruth B Caldwell; Robert William Caldwell
Journal:  J Sex Med       Date:  2010-08-30       Impact factor: 3.802

6.  Chronic oral administration of the arginase inhibitor 2(S)-amino-6-boronohexanoic acid (ABH) improves erectile function in aged rats.

Authors:  Robert Segal; Johanna L Hannan; Xiaopu Liu; Omer Kutlu; Arthur L Burnett; Hunter C Champion; Jae Hyung Kim; Jochen Steppan; Dan E Berkowitz; Trinity J Bivalacqua
Journal:  J Androl       Date:  2012-04-05

7.  Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout.

Authors:  Lin Yao; Surabhi Chandra; Haroldo A Toque; Anil Bhatta; Modesto Rojas; Ruth B Caldwell; R William Caldwell
Journal:  Cardiovasc Res       Date:  2012-12-17       Impact factor: 10.787

8.  Endothelin-1 Overexpression Exaggerates Diabetes-Induced Endothelial Dysfunction by Altering Oxidative Stress.

Authors:  Noureddine Idris-Khodja; Sofiane Ouerd; Muhammad Oneeb Rehman Mian; Jordan Gornitsky; Tlili Barhoumi; Pierre Paradis; Ernesto L Schiffrin
Journal:  Am J Hypertens       Date:  2016-11-01       Impact factor: 2.689

9.  Activated Rho kinase mediates diabetes-induced elevation of vascular arginase activation and contributes to impaired corpora cavernosa relaxation: possible involvement of p38 MAPK activation.

Authors:  Haroldo A Toque; Kenia P Nunes; Lin Yao; James K Liao; R Clinton Webb; Ruth B Caldwell; R William Caldwell
Journal:  J Sex Med       Date:  2013-04-08       Impact factor: 3.802

Review 10.  Arginase: A Multifaceted Enzyme Important in Health and Disease.

Authors:  R William Caldwell; Paulo C Rodriguez; Haroldo A Toque; S Priya Narayanan; Ruth B Caldwell
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.